Articles with public access mandates - Paul NeilsenLearn more
Not available anywhere: 1
New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity
PM Neilsen, AD Pehere, KI Pishas, DF Callen, AD Abell
ACS Chemical Biology 8 (2), 353-359, 2013
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 13
The oncogenic role of miR-155 in breast cancer
S Mattiske, RJ Suetani, PM Neilsen, DF Callen
Cancer epidemiology, biomarkers & prevention 21 (8), 1236-1243, 2012
Mandates: National Health and Medical Research Council, Australia
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
PAJ Muller, AG Trinidad, P Timpson, JP Morton, S Zanivan, ...
Oncogene 32 (10), 1252-1265, 2013
Mandates: Cancer Research UK
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
PM Neilsen, JE Noll, S Mattiske, CP Bracken, PA Gregory, RB Schulz, ...
Oncogene 32 (24), 2992-3000, 2013
Mandates: National Health and Medical Research Council, Australia
Ankrd11 is a chromatin regulator involved in autism that is essential for neural development
D Gallagher, A Voronova, MA Zander, GI Cancino, A Bramall, MP Krause, ...
Developmental cell 32 (1), 31-42, 2015
Mandates: Howard Hughes Medical Institute, Canadian Institutes of Health Research
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells
NT Pfister, V Fomin, K Regunath, JY Zhou, W Zhou, L Silwal-Pandit, ...
Genes & development 29 (12), 1298-1315, 2015
Mandates: Swiss National Science Foundation, US National Institutes of Health
p53 represses the oncogenic Sno-MiR-28 derived from a SnoRNA
F Yu, CP Bracken, KA Pillman, DM Lawrence, GJ Goodall, DF Callen, ...
PloS one 10 (6), e0129190, 2015
Mandates: National Health and Medical Research Council, Australia
Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome
K Walz, D Cohen, PM Neilsen, J Foster, F Brancati, K Demir, R Fisher, ...
Human genetics 134, 181-190, 2015
Mandates: National Health and Medical Research Council, Australia
Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer
R Shakya, GA Tarulli, L Sheng, NA Lokman, C Ricciardelli, KI Pishas, ...
Oncogene 36 (31), 4469-4480, 2017
Mandates: National Health and Medical Research Council, Australia
Synthesis and Extended Activity of Triazole‐Containing Macrocyclic Protease Inhibitors
AD Pehere, M Pietsch, M Gütschow, PM Neilsen, DS Pedersen, S Nguyen, ...
Chemistry–A European Journal 19 (24), 7975-7981, 2013
Mandates: Australian Research Council
Specific-site methylation of tumour suppressor ANKRD11 in breast cancer
SP Lim, NC Wong, RJ Suetani, K Ho, JL Ng, PM Neilsen, PG Gill, ...
European journal of cancer 48 (17), 3300-3309, 2012
Mandates: National Health and Medical Research Council, Australia
A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues
RJ Suetani, K Ho, S Jindal, J Manavis, PM Neilsen, KI Pishas, E Rippy, ...
Molecular and cellular endocrinology 362 (1-2), 202-210, 2012
Mandates: National Health and Medical Research Council, Australia
TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth
S Mattiske, K Ho, JE Noll, PM Neilsen, DF Callen, RJ Suetani
Oncotarget 4 (11), 1894, 2013
Mandates: National Health and Medical Research Council, Australia
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome
DF Callen, C Ricciardelli, M Butler, A Stapleton, J Stahl, JG Kench, ...
Oncology reports 23 (4), 1045-1052, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program